HK1043589A1 - Phenylalaninol derivatives. - Google Patents

Phenylalaninol derivatives.

Info

Publication number
HK1043589A1
HK1043589A1 HK02105393A HK02105393A HK1043589A1 HK 1043589 A1 HK1043589 A1 HK 1043589A1 HK 02105393 A HK02105393 A HK 02105393A HK 02105393 A HK02105393 A HK 02105393A HK 1043589 A1 HK1043589 A1 HK 1043589A1
Authority
HK
Hong Kong
Prior art keywords
alkyl
lower alkyl
alkanoyl
aryl
halo
Prior art date
Application number
HK02105393A
Other languages
English (en)
Inventor
Achytharao Sidduri
Jefferson Wright Tilley
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of HK1043589A1 publication Critical patent/HK1043589A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/77—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/80—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
HK02105393A 1999-02-18 2002-07-22 Phenylalaninol derivatives. HK1043589A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12049899P 1999-02-18 1999-02-18
PCT/EP2000/001168 WO2000048988A1 (en) 1999-02-18 2000-02-12 Phenylalaninol derivatives

Publications (1)

Publication Number Publication Date
HK1043589A1 true HK1043589A1 (en) 2002-09-20

Family

ID=22390691

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02105393A HK1043589A1 (en) 1999-02-18 2002-07-22 Phenylalaninol derivatives.

Country Status (29)

Country Link
US (1) US6420600B1 (xx)
EP (1) EP1154987B1 (xx)
JP (1) JP2002537283A (xx)
KR (1) KR100636458B1 (xx)
CN (1) CN1213020C (xx)
AT (1) ATE264835T1 (xx)
AU (1) AU771938B2 (xx)
BR (1) BR0008368A (xx)
CA (1) CA2362833C (xx)
CZ (1) CZ20012984A3 (xx)
DE (1) DE60010049T2 (xx)
DK (1) DK1154987T3 (xx)
ES (1) ES2218116T3 (xx)
HK (1) HK1043589A1 (xx)
HR (1) HRP20010594B1 (xx)
HU (1) HUP0200343A3 (xx)
ID (1) ID30057A (xx)
IL (2) IL144641A0 (xx)
MA (1) MA26772A1 (xx)
MX (1) MXPA01008178A (xx)
NO (1) NO20013946D0 (xx)
PL (1) PL349463A1 (xx)
PT (1) PT1154987E (xx)
RU (1) RU2238265C2 (xx)
SI (1) SI1154987T1 (xx)
TR (1) TR200102395T2 (xx)
WO (1) WO2000048988A1 (xx)
YU (1) YU58601A (xx)
ZA (1) ZA200106075B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6939855B2 (en) * 1997-07-31 2005-09-06 Elan Pharmaceuticals, Inc. Anti-inflammatory compositions and method
PL354063A1 (en) * 1999-08-13 2003-12-15 Biogen, Inc.Biogen, Inc. Cell adhesion inhibitors
US6388084B1 (en) 1999-12-06 2002-05-14 Hoffmann-La Roche Inc. 4-pyridinyl-n-acyl-l-phenylalanines
US6380387B1 (en) 1999-12-06 2002-04-30 Hoffmann-La Roche Inc. 4-Pyrimidinyl-n-acyl-l phenylalanines
AU2004240940A1 (en) 2003-05-20 2004-12-02 Genentech, Inc. Thiocarbamate inhibitors of alpha-4 integrins
WO2006081986A1 (en) * 2005-02-07 2006-08-10 F.Hoffmann-La Roche Ag Bambuterol and integrin inhibitor combination
WO2006094640A2 (en) * 2005-03-04 2006-09-14 F.Hoffmann-La Roche Ag Roflumilast and integrin inhibitor combination and method of treatment
IL172896A0 (en) * 2005-12-29 2006-06-11 Yeda Res & Dev Cxcr4 inhibition
US8877815B2 (en) 2010-11-16 2014-11-04 Novartis Ag Substituted carbamoylcycloalkyl acetic acid derivatives as NEP

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE584914A (xx) 1958-11-24
US3527793A (en) 1967-08-18 1970-09-08 Bristol Myers Co Phenylglycine derivatives
IT1190378B (it) 1985-06-21 1988-02-16 Isf Spa Derivati pirrolidonici
US5039805A (en) 1988-12-08 1991-08-13 Hoffmann-La Roche Inc. Novel benzoic and phenylacetic acid derivatives
US5463116A (en) 1991-07-30 1995-10-31 Ajinomoto Co., Inc. Crystals of N- (trans-4-isopropylcyclohexlycarbonyl)-D-phenylalanine and methods for preparing them
ATE210663T1 (de) 1994-06-20 2001-12-15 Takeda Chemical Industries Ltd Kondensierte imidazolderivate, ihre herstellung und verwendung
US6306840B1 (en) 1995-01-23 2001-10-23 Biogen, Inc. Cell adhesion inhibitors
US5804595A (en) 1995-12-05 1998-09-08 Regents Of The University Of Minnesota Kappa opioid receptor agonists
JP2000515493A (ja) * 1996-03-29 2000-11-21 ジー．ディー．サール アンド カンパニー パラ―置換フェニレン誘導体
JP2000506538A (ja) 1996-03-29 2000-05-30 ジー．ディー．サール アンド カンパニー メタ―置換フェニレン誘導体
ID19155A (id) * 1996-12-13 1998-06-18 Tanabe Seiyaku Co Turunan-turunan piridin, pembuatannya dan intermediet untuk pembuatannya
JP2002512625A (ja) * 1997-05-29 2002-04-23 メルク エンド カンパニー インコーポレーテッド 細胞接着阻害薬としての複素環アミド化合物
CA2300121A1 (en) * 1997-08-22 1999-03-04 F. Hoffmann-La Roche Ag N-alkanoylphenylalanine derivatives
NZ502813A (en) * 1997-08-22 2002-10-25 F N-aroylphenylalanine derivatives as inhibitors of the interaction between a4 containing integrins and VCAM-1
US6555562B1 (en) 1998-02-26 2003-04-29 Celltech R&D Limited Phenylalanine derivatives
US6521626B1 (en) 1998-03-24 2003-02-18 Celltech R&D Limited Thiocarboxamide derivatives
GB9811159D0 (en) 1998-05-22 1998-07-22 Celltech Therapeutics Ltd Chemical compounds

Also Published As

Publication number Publication date
IL144641A (en) 2006-09-05
TR200102395T2 (tr) 2001-12-21
SI1154987T1 (en) 2004-08-31
BR0008368A (pt) 2001-11-06
CA2362833A1 (en) 2000-08-24
AU2548600A (en) 2000-09-04
KR100636458B1 (ko) 2006-10-18
US6420600B1 (en) 2002-07-16
HUP0200343A3 (en) 2005-04-28
EP1154987A1 (en) 2001-11-21
ZA200106075B (en) 2002-10-24
IL144641A0 (en) 2002-05-23
CN1213020C (zh) 2005-08-03
JP2002537283A (ja) 2002-11-05
MXPA01008178A (es) 2002-03-13
ID30057A (id) 2001-11-01
DE60010049T2 (de) 2005-03-31
DK1154987T3 (da) 2004-08-09
YU58601A (sh) 2004-05-12
NO20013946L (no) 2001-08-14
AU771938B2 (en) 2004-04-08
CA2362833C (en) 2009-04-07
HRP20010594B1 (en) 2006-02-28
NO20013946D0 (no) 2001-08-14
HRP20010594A2 (en) 2002-08-31
DE60010049D1 (de) 2004-05-27
CN1340043A (zh) 2002-03-13
MA26772A1 (fr) 2004-12-20
HUP0200343A2 (en) 2002-06-29
ATE264835T1 (de) 2004-05-15
WO2000048988A1 (en) 2000-08-24
CZ20012984A3 (cs) 2002-02-13
RU2238265C2 (ru) 2004-10-20
PT1154987E (pt) 2004-08-31
KR20010102260A (ko) 2001-11-15
ES2218116T3 (es) 2004-11-16
EP1154987B1 (en) 2004-04-21
PL349463A1 (en) 2002-07-29

Similar Documents

Publication Publication Date Title
HK1043589A1 (en) Phenylalaninol derivatives.
PL315030A1 (en) Method of bonding a flexible material with its associated substrate and product obtained thereby
MY144184A (en) Disposable wearing article
ZA200106180B (en) Thioamide derivatives.
ZA200203533B (en) 4-pyrimidinyl-N-acyl-L-phenylalanines.
EP1329459A3 (en) Monoclonal antibodies against the interferon receptor, with neutralizing activity against type I interferon
ATE204471T1 (de) Pyrimidin- oder triazincarbonsäurederivate zur verwendung als arzneimittel
BR9609092A (pt) Prendedores de aba de fita para artigos absorventes descartáveis
PL321593A1 (en) Method of actiwating biological tissue gluing adhesives, bonding agents and haemorrhage arresting agents by use colour-changing chromophores
NZ335318A (en) (o-acyl-p-N-acylamino-phenyl)-O-phosphoethanolamines with anti-inflammatory activity
DE3880499D1 (de) Cyanhydrinderivate und deren verwendung in fluessigkristallmaterialien und vorrichtungen.
HUP0302440A2 (hu) Amino-kinolin származékok, eljárás előállításukra és ezeket hatóanyagként tartalmazó gyógyszerkészítmények
HUP0401467A2 (en) Aminoquinoline derivatives, process for producing them and their use as adenosine a3 ligands

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20090212